We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Polar Capital Global Healthcare Trust plc (PCGH) Ordinary 25p Shares

Sell:351.00p Buy:352.00p 0 Change: 2.00p (0.56%)
FTSE All Share:0.18%
Market closed |  Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:351.00p
Buy:352.00p
Change: 2.00p (0.56%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:351.00p
Buy:352.00p
Change: 2.00p (0.56%)
Market closed |  Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
353.00p
Trade high:
355.50p
Year high:
400.00p
Estimated NAV:
372.58
Previous close:
354.00p
Trade low:
350.00p
Year low:
321.00p
Premium/Discount:
-4.99%
Previous:
6.00p (1.67%) Previous:
6.00p
Volume:
217,112
Dividend yield:
0.68%
Currency:
GBX
Data delayed by at least 15 minutes.

Share chart Chart

Price

  • Net Asset Value (NAV)
POLAR CAP GLBL performance chart

The chart is based on estimated NAV but will be updated with actual NAV when available.

Premium/Discount

POLAR CAP GLBL performance chart
Full interactive share price and premium / discount charts

Performance

1 week 1W 2.76% 1 year 1Y 8.64%
1 month 1M 3.03% 2 years 2Y 7.65%
3 months 3M 9.28% 3 years 3Y 19.52%
6 months 6M 5.63% 5 years 5Y 47.28%

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Trust Basics

Benchmark: MSCI ACWI/Health Care NR GBP enhanced
Annual management charge: n/a
Performance fee: Yes
Ongoing charge: 0.88%
Dividend yield: 0.68%
Dividend frequency: Semi-Annually
Total assets: £452m
Gross gearing: 0%
Market capitalisation:Market cap.: £429m
Shares in issue: 121.27 million
Legal structure Closed Ended Investment Company
Domicile: United Kingdom
ISIN GB00B6832P16

Recent dividends paid or declared by Polar Capital Global Healthcare Trust plc:

Type Ex-div date Payment date Amount
2nd interim * 06/02/2025 28/02/2025 1.20p
1st interim 01/08/2024 30/08/2024 1.20p
2nd interim 01/02/2024 29/02/2024 1.20p
1st interim 03/08/2023 31/08/2023 1.00p
2nd interim 02/02/2023 28/02/2023 1.10p

* Dividend has not yet been paid but has been declared by Polar Capital Global Healthcare Trust plc.

This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.

Full dividend history

Five years' total annual Polar Capital Global Healthcare Trust plc dividends:

Financial
year end		 Dividend
yield		 Dividend
cover		 Total dividend
paid
30/09/2024 0.60% 1.12 2.40p
30/09/2023 0.70% 1.10 2.20p
30/09/2022 0.70% 1.07 2.10p
30/09/2021 0.70% 0.91 2.00p
30/09/2020 0.90% 0.73 2.00p

All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.

Full dividend history

Ready to invest?

Invest now

Want to invest?

To buy shares in , you'll need to have an account.

Explore the options

Important Documents



Objective

The Company’s investment objective is to generate capital growth by investing in a global portfolio of healthcare stocks.The Company seeks to achieve this objective by investing in a diversified global portfolio consisting primarily of listed equities issued by healthcare companies involved in pharmaceuticals, medical services, medical devices and biotechnology. The portfolio is expected to be diversified by factors such as geography, industry sub-sector and investment size.

NET ASSET VALUE (NAV)

Estimated NAV: 372.58p
Latest actual NAV: 374.19p
Latest actual NAV date: 18 December 2024
Premium/Discount: -4.99%
12m average Premium/Discount: -5.65%
NAV frequency: Daily
Security Weight
Eli Lilly and Co 8.26%
UnitedHealth Group Inc 7.55%
Novo Nordisk DKK0.1 B 6.01%
AbbVie Inc 5.05%
Roche Holdings AG NPV 4.50%
Sandoz Group AG CHF0.05 3.53%
Sanofi Ordinary Euro 2 3.32%
Terumo Corp 3.29%
Fresenius SE & Co KGaA NPV 3.20%
Intuitive Surgical Inc 3.18%
Sector Weight
Healthcare 99.86%
Country Weight
United States 47.39%
Switzerland 12.92%
Denmark 11.41%
Japan 6.25%
France 5.67%
Germany 3.20%
Belgium 3.12%
Sweden 3.07%
United Kingdom 2.37%
Italy 1.91%

Key Dates

Launch date: 15 June 2010
Financial year end: September
Next AGM: February 2025

Annual & interim reports

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. Dividend data provided by Digital Look. Recent trade data provided by MoneyAM. Trust basics, holding data, key dates, objective and NAV provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.